Genomic imbalances in peripheral blood confirm the diagnosis of myelodysplastic syndrome in a patient presenting with non-immune hemolytic anemia

Rummens, 1986, Elliptocytosis and schistocytosis in myelodysplasia: report of two cases, Acta Haematol., 75, 1747, 10.1159/000206114 Ishida, 1999, Elliptocytosis in myelodysplastic syndrome associated with translocation (1;5)(p10;q10) and deletion of 20q, Cancer Genet. Cytogenet., 108, 162, 10.1016/S0165-4608(98)00135-6 Aleem, 2001, Spherocytosis preceding the development of myelodysplasia, Clin. Lab. Haematol., 23, 249, 10.1046/j.1365-2257.2001.00385.x de Thé, 1990, The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus, Nature, 347, 558, 10.1038/347558a0 Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature, 1973, 43, pp. 290–293. In: Landmarks in Medical Genetics: Classic Papers with Commentaries 2004, 51, p. 104. Greenberg, 2012, Revised international prognostic scoring system for myelodysplastic syndromes, Blood, 120, 2454, 10.1182/blood-2012-03-420489 Tiu, 2011, Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies, Blood, 117, 4552, 10.1182/blood-2010-07-295857 Jasek, 2010, TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p, Leukemia, 24, 216, 10.1038/leu.2009.189 Maciejewski, 2009, Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies, Br. J. Haematol., 146, 479, 10.1111/j.1365-2141.2009.07757.x Roberts, 2012, CD45-deficient severe combined immunodeficiency caused by uniparental disomy, Proc. Natl. Acad. Sci. USA, 109, 10456, 10.1073/pnas.1202249109 Lin, 2002, Myelodysplastic syndrome complicated by autoimmune hemolytic anemia: remission of refractory anemia following mycophenolate mofetil, Ann. Hematol., 81, 723, 10.1007/s00277-002-0539-3 Hartz, 1984, Marked elliptocytosis and schistocytosis in hematopoietic dysplasia, Am. J. Clin. Pathol., 82, 354, 10.1093/ajcp/82.3.354 Atkins, 1985, Schistocytes in erythroleukemia, Am. J. Med. Sci., 289, 110, 10.1097/00000441-198503000-00004 Doll, 1987, Acanthocytosis associated with myelodysplasia, J. Clin. Oncol., 7, 1569, 10.1200/JCO.1989.7.10.1569 Visudhiphan, 1983, Erythrocyte fragmentation in disseminated intravascular coagulation and other diseases, N. Engl. J. Med., 309, 113, 10.1056/NEJM198307143090217 Druker, 2006, Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia, N. Engl. J. Med., 355, 2408, 10.1056/NEJMoa062867 Kohlmann, 2014, Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing, Leuk. Lymphoma, 55, 1725, 10.3109/10428194.2013.856427 Metzker, 2010, Sequencing technologies – the next generation, Nat. Rev. Genet., 11, 31, 10.1038/nrg2626 Margulies, 2005, Genome sequencing in microfabricated high-density picolitre reactors, Nature, 437, 376, 10.1038/nature03959 Bentley, 2008, Accurate whole human genome sequencing using reversible terminator chemistry, Nature, 456, 53, 10.1038/nature07517